The hallmarks of successful anticancer immunotherapy

dc.contributor.author	Galluzzi, L.
dc.contributor.author	Chan, T. A.
dc.contributor.author	Kroemer, Guido
dc.contributor.author	Wolchok, J. D.
dc.contributor.author	López Soto, Alejandro
dc.date.accessioned	2019-01-30T07:58:07Z
dc.date.available	2019-01-30T07:58:07Z
dc.date.issued	2018
dc.identifier.citation	Science Translational Medicine, 10(459), p. eaat7807- (2018); doi:10.1126/scitranslmed.aat7807
dc.identifier.issn	1946-6234
dc.identifier.uri	http://hdl.handle.net/10651/49975
dc.format.extent	p. eaat7807-
dc.language.iso	eng
dc.relation.ispartof	Science Translational Medicine, 10
dc.rights	© 2018 Galluzzi et al.
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053503895&doi=10.1126%2fscitranslmed.aat7807&partnerID=40&md5=ec3de4d8786c69f75db2f96322442a89
dc.title	The hallmarks of successful anticancer immunotherapy	eng
dc.type	journal article
dc.identifier.doi	10.1126/scitranslmed.aat7807
dc.relation.publisherversion	http://dx.doi.org/10.1126/scitranslmed.aat7807

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.